MELISSA RAMDAS: Open Payments
NPI 1568664704 · WEST ORANGE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$327 in 12 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $41 · 2025 $327
Food & beverage: $327
| Company | Payments | Amount |
|---|---|---|
| Reprise Biomedical, Inc. | 3 | $90 |
| Solventum Corporation | 3 | $68 |
| Philips North America LLC | 1 | $58 |
| Paratek Pharmaceuticals, Inc. | 2 | $35 |
| Bioventus LLC | 1 | $33 |
| Averitas Pharma Inc. | 1 | $30 |
| Smith+Nephew, Inc. | 1 | $14 |
Products named: Miro 3D, ACTIV.A.C., Zenition 90, NUZYRA, EXOGEN ULTRASOUND BONE HEALING SYSTEM, QUTENZA, COLLAGENASE SANTYL, Miro3D.
Industry payments across NJ — which companies pay providers there.
